{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T08:12:54Z","timestamp":1770883974449,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.humpath.2011.06.003","type":"journal-article","created":{"date-parts":[[2011,8,21]],"date-time":"2011-08-21T04:38:26Z","timestamp":1313901506000},"page":"669-674","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["SCARA3 mRNA is overexpressed in ovarian carcinoma compared with breast carcinoma effusions"],"prefix":"10.1016","volume":"43","author":[{"given":"Annika J.","family":"Bock","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dag Andre","family":"Nymoen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kjersti","family":"Brenne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janne","family":"K\u00e6rn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2011.06.003_bb0005","first-page":"277","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.humpath.2011.06.003_bb0010","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMra041842","article-title":"Cancer of the ovary","volume":"351","author":"Cannistra","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2011.06.003_bb0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/gyno.1996.4550","article-title":"Stage IV ovarian cancer: impact of surgical debulking","volume":"64","author":"Curtin","year":"1997","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2011.06.003_bb0020","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1006\/gyno.1998.5145","article-title":"Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer","volume":"72","author":"Bristow","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2011.06.003_bb0025","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1200\/JCO.1999.17.3.767","article-title":"Natural history of stage IV epithelial ovarian cancer","volume":"17","author":"Bonnefoi","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2011.06.003_bb0030","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/dc.20133","article-title":"Malignant effusions: from diagnosis to biology","volume":"31","author":"Davidson","year":"2004","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.humpath.2011.06.003_bb0035","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1582-4934.2010.01019.x","article-title":"Gene expression signatures differentiate ovarian\/peritoneal serous carcinoma from breast carcinoma in effusions","volume":"15","author":"Davidson","year":"2011","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.humpath.2011.06.003_bb0040","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/hmg\/7.6.1039","article-title":"CSR, a scavenger receptor-like protein with a protective role against cellular damage caused by UV irradiation and oxidative stress","volume":"7","author":"Han","year":"1998","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.humpath.2011.06.003_bb0045","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2353\/ajpath.2006.050620","article-title":"CSR1 suppresses tumor growth and metastasis of prostate cancer","volume":"168","author":"Yu","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2011.06.003_bb0050","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/onc.2008.359","article-title":"CSR1 induces cell death through inactivation of CPSF3","volume":"28","author":"Zhu","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2011.06.003_bb0055","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s004280050393","article-title":"Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies. Evaluation of five epithelial markers","volume":"435","author":"Davidson","year":"1999","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2011.06.003_bb0060","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1097\/00000478-200111000-00008","article-title":"The role of desmin and N-cadherin in effusion cytology: a comparative study using established markers of mesothelial and epithelial cells","volume":"25","author":"Davidson","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2011.06.003_bb0065","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1097\/PAS.0b013e3181b6bde3","article-title":"Tenascin-X is a novel diagnostic marker of malignant mesothelioma","volume":"33","author":"Yuan","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2011.06.003_bb0070","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1038\/sj.leu.2403136","article-title":"Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using \u2018real-time\u2019 quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR)\u2014a Europe against cancer program","volume":"17","author":"Beillard","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2011.06.003_bb0075","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer treatment","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2011.06.003_bb0080","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/nbt1236","article-title":"Evaluation of DNA microarray results with quantitative gene expression platforms","volume":"24","author":"Canales","year":"2006","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.humpath.2011.06.003_bb0085","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.humpath.2009.02.013","article-title":"Expression of the folate receptor genes FOLR1 and FOLR3 differentiates ovarian carcinoma from breast carcinoma and malignant mesothelioma in serous effusions","volume":"40","author":"Yuan","year":"2009","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2011.06.003_bb0090","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1677\/jme.1.01755","article-title":"Quantitative real-time RT-PCR\u2014a perspective","volume":"34","author":"Bustin","year":"2005","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.humpath.2011.06.003_bb0095","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1615\/CritRevOncog.v13.i3.10","article-title":"Biological characteristics of cancers involving the serosal cavities","volume":"13","author":"Davidson","year":"2007","journal-title":"Crit Rev Oncog"},{"key":"10.1016\/j.humpath.2011.06.003_bb0100","first-page":"1591","article-title":"New determinates of disease progression and outcome in metastatic ovarian carcinoma","volume":"25","author":"Davidson","year":"2010","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.humpath.2011.06.003_bb0105","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/gb-2003-4-9-117","article-title":"Comparing protein abundance and mRNA expression levels on a genomic scale","volume":"4","author":"Greenbaum","year":"2003","journal-title":"Genome Biol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817711002528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817711002528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:32:57Z","timestamp":1758645177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817711002528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0046817711002528"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2011.06.003","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SCARA3 mRNA is overexpressed in ovarian carcinoma compared with breast carcinoma effusions","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2011.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}